She calls it a whole new way to manage weight
Retatrutide Availability Retatrutide is not yet approved for prescription use in any jurisdiction
If you think youve taken too much, seek emergency medical care right away
The MHRA approved a higher 7.2 mg dose of Wegovy in January 2026, which gave an average weight loss of 20.7%, around 1 to 2 percentage points lower than Mounjaro 15 mg
With commercial insurance and a manufacturer savings card, Wegovy and Zepbound can cost as little as $25 per fill
Whilst both medications are licensed for weight management in adults with obesity or overweight with weight-related comorbidities, they differ significantly in their mechanism of action, administration route, side effect profiles, and clinical effectiveness